Re: Tea Leaves
|
6
|
Resverlogix Corp.
|
Jan 24, 2021 09:49AM
|
Re: RVX Announces Update Webcast and Conference Call
|
5
|
Resverlogix Corp.
|
Jan 18, 2021 12:10PM
|
Re: Saudi
|
5
|
Resverlogix Corp.
|
Jan 15, 2021 02:40PM
|
Re: Saudi
|
2
|
Resverlogix Corp.
|
Jan 15, 2021 01:27PM
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
2
|
Resverlogix Corp.
|
Jan 12, 2021 05:16PM
|
Re: Saudi
|
1
|
Resverlogix Corp.
|
Jan 12, 2021 02:18PM
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
10
|
Resverlogix Corp.
|
Jan 12, 2021 02:15PM
|
Re: Price
|
4
|
Resverlogix Corp.
|
Dec 30, 2020 11:32AM
|
Re: My New Year's wish if for RVX to get a deal structured similarly to MYOV...
|
6
|
Resverlogix Corp.
|
Dec 29, 2020 08:17AM
|
Re: Merry Christmas RVX posters
|
6
|
Resverlogix Corp.
|
Dec 25, 2020 10:46AM
|
Re: Anyone.....
|
2
|
Resverlogix Corp.
|
Dec 22, 2020 03:02PM
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
2
|
Resverlogix Corp.
|
Dec 22, 2020 09:58AM
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
3
|
Resverlogix Corp.
|
Dec 22, 2020 09:38AM
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
5
|
Resverlogix Corp.
|
Dec 22, 2020 09:26AM
|
Re: Award of deferred shares and restricted shares
|
5
|
Resverlogix Corp.
|
Dec 21, 2020 01:16PM
|
Re: Pitchforks
|
2
|
Resverlogix Corp.
|
Dec 19, 2020 08:01AM
|
Re: RVX Level II - Narmac
|
2
|
Resverlogix Corp.
|
Dec 11, 2020 12:51PM
|
Re: Sorry, did I miss something?
|
3
|
Resverlogix Corp.
|
Dec 09, 2020 08:15PM
|
Re: By Christmas time.....
|
1
|
Resverlogix Corp.
|
Dec 09, 2020 01:35PM
|
Re: By Christmas time.....
|
3
|
Resverlogix Corp.
|
Dec 09, 2020 01:01PM
|